Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans

Summary Thrombin is a coagulation protease that activates platelets, endothelial cells, leukocytes and mesenchymal cells. Thrombin signaling is mediated at least in part by protease-activated receptors (PARs). As little is known about the in vivoregulation of PAR1, this study aimed to characterize the effects of systemic thrombin formation during human endotoxemia on the regulation of PAR1 and the associated responsiveness of human platelets to thrombin receptor activating peptide (TRAP). Endotoxin (2 ng/kg) was infused into 40 healthy men to study the regulation of PAR1 in systemic human inflammation. The SPAN12 antibody was used to determine the in vivoregulation of PAR1. To measure whether modulation of the PAR1 receptor may be associated with altered platelet reactivity, whole blood was stimulated with TRAP ex vivo. Thrombin generation was determined by prothrombin (F1+2) fragment. F1+2levels increased almost 9-fold from 0.5±0.1 nmol/L to 4.5±1.9 nmol/L at 4 h (p<0.001). PAR1 decreased by ~8% (p<0.001) within 2 h after endotoxin infusion and stayed at those levels until 6 h. Concomitantly, TRAP induced P-selectin expression maximally decreased by 18% (p<0.001) at 6 h. In conclusion, PAR1 expression is down-regulated on platelets during systemic thrombin formation induced by inflammation in humans which results in decreased responsiveness to subsequent stimulation of the PAR1 receptor.

[1]  I. Bièche,et al.  An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. , 2003, Blood.

[2]  H. Eichler,et al.  Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans , 2002, Clinical pharmacology and therapeutics.

[3]  H. Eichler,et al.  Acenocoumarol decreases tissue factor–dependent coagulation during systemic inflammation in humans , 2002, Clinical pharmacology and therapeutics.

[4]  B. Jilma.  Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. , 2001, The Journal of laboratory and clinical medicine.

[5]  S. Coughlin.  Protease-activated Receptors in Vascular Biology , 2001, Thrombosis and Haemostasis.

[6]  H. Eichler,et al.  Effects of anticoagulation on thrombopoietin release during endotoxemia. , 2001, The Journal of laboratory and clinical medicine.

[7]  H. Eichler,et al.  Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100 , 2000 .

[8]  H. Eichler,et al.  Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. , 2000, Blood.

[9]  S. Coughlin,et al.  A MUTANT HeLa CELL LINE SUGGESTS NOVEL REQUIREMENTS FOR PAR1 PHOSPHORYLATION AND RECRUITMENT TO CLATHRIN-COATED PITS* , 2000 .

[10]  H. Eichler,et al.  Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans , 1999, Transfusion.

[11]  H. Eichler,et al.  Effects of Endotoxemia on Thrombopoiesis in Men , 1999, Thrombosis and Haemostasis.

[12]  S. Coughlin,et al.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. , 1999, The Journal of clinical investigation.

[13]  M. Recht,et al.  Differences in Platelet α-granule Release between Normals and Immune Thrombocytopenic Patients and between Young and Old Platelets , 1998, Thrombosis and Haemostasis.

[14]  R. Colman,et al.  Recombinant Tumor Necrosis Factor Receptor p75 Fusion Protein (TNFR:Fc) Alters Endotoxin-Induced Activation of the Kinin, Fibrinolytic, and Coagulation Systems in Normal Humans , 1998, Thrombosis and Haemostasis.

[15]  E. Mammen.  The haematological manifestations of sepsis. , 1998, The Journal of antimicrobial chemotherapy.

[16]  J. Loscalzo,et al.  In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Davidson,et al.  Description of an In Vitro Platelet Function Analyzer-PFA-100™ , 1995, Seminars in Thrombosis & Hemostasis.

[18]  K. Pumiglia,et al.  Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. , 1994, The Biochemical journal.

[19]  J. Hoxie,et al.  Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. , 1994, The Journal of biological chemistry.

[20]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[21]  H. Gralnick,et al.  von Willebrand factor release induced by endotoxin. , 1989, The Journal of laboratory and clinical medicine.